164638-24-8

Basic information

• Product Name: tropomyosin-4
• Synonyms: tropomyosin-4;wu:fb06e07;zgc:103436;zgc:63909;Anti-TPM4 antibody produced in rabbit;TPM4;ANTI-TPM4 (N-TERM) antibody produced in rabbit;Tropomyosin alpha-4 chain
• CAS NO: 164638-24-8
• Molecular Weight: 0
• Mol File: 164638-24-8.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: -20°C
• CAS DataBase Reference: tropomyosin-4(CAS DataBase Reference)
• NIST Chemistry Reference: tropomyosin-4(164638-24-8)
• EPA Substance Registry System: tropomyosin-4(164638-24-8)

Safety Data

• Hazardous Substances Data: 164638-24-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Tropomyosin-4 is used as a target for drug development for the treatment of muscular disorders. Its role in muscle function and structure makes it a promising candidate for the development of therapeutic agents that can modulate its activity or expression to alleviate symptoms associated with muscular disorders.
Used in Research Applications:
Tropomyosin-4 is used as a research tool for studying the molecular mechanisms of muscle contraction and relaxation. Its involvement in the interaction between actin and myosin makes it an important protein for understanding the regulation of muscle function. Additionally, studying the role of tropomyosin-4 in muscular disorders can provide insights into the pathophysiology of these conditions and aid in the development of novel therapeutic strategies.
Used in Diagnostic Applications:
Tropomyosin-4 can be used as a biomarker for the diagnosis of muscular disorders associated with abnormalities in the TPM4 gene. Detection of changes in the expression or activity of tropomyosin-4 can help in the early identification of these conditions, allowing for timely intervention and management.
Used in Drug Screening and Development:
Tropomyosin-4 can be used in drug screening assays to identify compounds that can modulate its activity or interaction with other muscle proteins. These compounds can then be further developed as potential therapeutic agents for the treatment of muscular disorders.